Álvaro Aparisi, Pablo Catalá, Ignacio J Amat-Santos, Marta Marcos-Mangas, Diego López-Otero, Carlos Veras, Javier López-Pais, Gonzalo Cabezón-Villalba, Carla Eugenia Cacho Antonio, Jordi Candela, Pablo Antúnez-Muiños, José Francisco Gil, Teba González Ferrero, Gino Rojas, Marta Pérez-Poza, Aitor Uribarri, Oscar Otero-García, Pablo Elpidio García-Granja, Víctor Jiménez Ramos, Ana Revilla, Carlos Dueñas, Itzíar Gómez, José Ramón González-Juanatey, J Alberto San Román
BACKGROUND: Hypertension is a prevalent condition among SARS-CoV-2 infected patients. Whether renin-angiotensin-aldosterone system (RAAS) inhibitors are beneficial or harmful is controversial. METHODS: We have performed a national retrospective, nonexperimental comparative study from two tertiary hospitals to evaluate the impact of chronic use of RAAS inhibitors in hypertensive COVID-19 patients. A meta-analysis was performed to strengthen our findings. RESULTS: Of 849 patients, 422 (49...
May 6, 2021: Medicina Clínica